Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Promentis Pharmaceuticals

Promentis Pharmaceuticals

A biopharmaceutical company developing therapiesfor the treatment of central nervous system disorders

Overview Structured Data Issues Contributors Activity

promentispharma.com

Is a

Company attributes

Industry

Biomedical engineering

...

Location

0

CEO

0

Founder

0

0

AngelList URL

angel.co/promentis-...maceuticals

Pitchbook URL

pitchbook.com/profiles.../56612-53

Email Address

contact@promentispharma.com0

Full Address

826 N. Plankinton Ave., Suite 400 Milwaukee, WI 532030

Investors

Marquette Golden Angels

0

National Institute of Mental Health

0

0

Aisling Capital

0

Golden Angels Investors

0

0

DUNS Number

794082193

Total Funding Amount (USD)

26,000,000

Latest Funding Round Date

March 30, 2017

Latest Funding Type

Patents Assigned (Count)

9

Wellfound ID

promentis-pharmaceuticals

Country

0

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Promentis Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool